MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    The effect of comorbid chronic post-traumatic stress disorder in dream enactment behavior among veterans with Parkinson’s disease and REM sleep behavior disorder

    E. Sandoval, C. Josephs, T. Lin (Tucson, USA)

    Objective: 1. To determine the co-occurrence rate of PTSD in veterans with PD and RBD.2. To evaluate severity of dream enactment behavior (DEB) and rate…
  • 2024 International Congress

    Influence of Fatigue in Parkinson’s Disease on Variability of Gait Measures

    I. Sierra, S. Perfetto, A. Potvin-Desrochers, C. Mvomo, J. Bedime, H. Lajeunesse, F. Parent-L'Ecuye, C. Paquette (Montreal, Canada)

    Objective: This project aims to explore the experience of fatigue in Parkinson’s patients, and its influence on gait variability in stride frequency and ground contact…
  • 2024 International Congress

    Obsessive-Compulsive Disorder Prevalence in Parkinson’s Disease Caregivers

    F. Hojjatipour, M. Salari (tehran, Islamic Republic of Iran)

    Objective: Our goal is to assess the prevalence of obsessive-compulsive disorder (OCD) among those who provide care for individuals with Parkinson's disease (PD). Additionally, we…
  • 2024 International Congress

    Functional Motor Disorders in pediatrics: motor patterns and clinical correlates.

    V. Baglioni, C. Geroin, D. Esposito, F. Teatini, A. Tessitore, G. Calandra-Buonaura, M. Zibetti, R. Erro, F. Morgante, A. Albanese, F. Bono, M. Zappia, G. Defazio, E. Marcuzzo, A. Sandri, M. Tinazzi (Rome, Italy)

    Objective: The aim of this study was to describe FMDs clinical manifestations in pediatrics, including non-motor symptoms and other functional neurological disorders (FNDs) and to…
  • 2024 International Congress

    Craniofacial Myoclonus: A Disabling Complication of Amantadine Therapy

    S. Bhushan, Mph, S. Brillman, Md (Palo Alto, USA)

    Objective: We describe a patient who developed amantadine-induced craniofacial myoclonus with speech impairment. Few cases have been reported [1], thus we offer an additional case…
  • 2024 International Congress

    Validation of PD Ascertainment in the VA Electronic Medical Record (EMR)

    S. Goldman, F. Weaver, L. Cao, S. Jugnundan, B. Gonzalez, K. Stroupe, K. Colletta, E. Brown, C. Tanner (San Francisco, USA)

    Objective: To determine the validity of PD diagnostic codes in a large national electronic medical database and develop recommendations for maximizing ascertainment accuracy. Background: EMR-based…
  • 2024 International Congress

    Prevalence of Advanced Parkinson’s Disease and Potential Candidacy for Device-Aided Therapies in the Casablanca Region: Preliminary Results of a Multicenter Regional Study

    M. Daghi, A. Lakhdar, H. El Otmani (Casablanca, Morocco)

    Objective: This preliminary study aims to investigate the prevalence of advanced Parkinson's disease (PD) among patients receiving treatment in the Casablanca region of Morocco. Background:…
  • 2024 International Congress

    No Association between Anemia and Risk of Parkinson’s Disease: Evidence From A Meta-Analysis Using Real-World Evidence

    S. Zayed, S. Tabassum (Ranchi, India)

    Objective: To explore the association between anemia and the risk of Parkinson’s disease. Background: Parkinson’s disease (PD) is a common progressive neurodegenerative neurological disorder. More than…
  • 2024 International Congress

    Depressive Symptomatology and Neuropsychiatric Profile in Patients with Idiopathic Parkinson’s Disease without Dementia (IPDWD). Preliminary Data from a New Scale Specifically for Measuring Depression in Patients with IPDWD.

    C A. Hurtado-Gonzalez, J F. Ayala-Rico, S. Ospina-Otalvaro, J M. Márquez, L. Ortega-Bolaños, D A. Reyes-Torres, P A. Gutiérrez-Lenis, L M. Saldarriaga, C O. Moreno (Cali, Colombia)

    Objective: : To identify whether depression in patients with IPDWD correlates with different types of behavioral symptoms. Background: Depression is considered a frequent neuropsychiatric pathology…
  • 2024 International Congress

    Exploring the Feasibility of Telerehabilitation for Balance Deficits in People with PD; the TelePD Trial

    L. King, C. Silva-Batista, J. Wilhelm, K. Scanlan, M. Stojak, P. Carlson-Kuhta, W. Liu, F. Horak, M. Mancini (Portland, USA)

    Objective: To evaluate the feasibility of adapting our Agility Boot Camp (ABC) for balance telerehabilitation (Tele-ABC) in people with mild-to-moderate Parkinson’s disease (PD). Background: Balance impairments…
  • « Previous Page
  • 1
  • …
  • 125
  • 126
  • 127
  • 128
  • 129
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Life expectancy with and without Parkinson’s disease in the general population
  • Advanced Search
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley